The neurological complications of Borrelia burgdorferi infection have only recently been recognised in the United Kingdom.' A similar neurological disorder, now also known to be often due to B. burgdorferi infection, has long been described in other parts of Europe (Bannwarth's syndrome)2 and more recently in the United States (Lyme disease). 3 Bannwarth described a group of patients with severe radicular pains, or lower motor neuron facial palsies, and a CSF lymphocytic pleocytosis which resolved spontaneously. The neurological manifestations of Lyme disease are similar though additional neurological abnormalities have been described.
The precise spectrum of the neurological complications of B. burgdorferi infection is unclear. Recent reports have suggested that acute transverse myelitis4 and chronic parenchymal neurological disease' also occur. Differences in the neurological complications of B. burgdorferi infections may exist between Europe and the United States just as arthritis, another manifestation of B. burgdorferi infection, appears less common in Europe. 6 Antigenic differences in the respective species of B. burgdorferi are known to exist and it has been suggested that they are responsible for these varied manifestations.7
Since we became aware of the neurological complications in the UK we have seen eight patients who contracted the disease in the New Forest area of Hampshire. We now report these cases to emphasise the occurrence of the disorder in this country and to draw attention to the type of neurological complications seen in the United Kingdom.
Clinical details of these eight patients are summarised in the table. The case histories of four patients are described in detail to illustrate the different types of neurological presentation. Patient 2 (Bannwarth's syndrome) This 59 year old woman discovered a tick on her lower abdomen when she got up one morning. She remained well for the next 5 weeks until she noticed a burning pain over her right eye and in her right arm. Two days later the right side of her face dropped and a few days later a rash appeared on her right upper thigh. Examination showed that she had a right lower motor neuron facial palsy and a rash compatible with erythema chronicum migrans. She was initially presumed to have a Bell's palsy and was treated with oral prednisolone (15 mg) daily, but when the rash appeared she received tetracycline. Whilst on treatment she continued to have burning pains in both arms, her chest and abdomen. Following treatment with tetracycline her rash faded almost immediately and her other symptoms resolved in a week. Her facial palsy did not begin to recover for another 2 weeks but then resolved within 1 week. She has remained well subsequently.
Patient 3 (Bannwarth's syndrome; cerebellar syndrome) Three weeks before admission this 28 year old woman developed morning headache and vomiting which became gradually worse. After 10 days the headaches improved but she developed a left lower motor neuron facial palsy. Three days later she became sick and dizzy and developed a right lower motor neuron facial palsy followed by some improvement in her systemic symptoms. There was no history of a tick bite or skin rash. Examination showed that she had bilateral lower motor neuron facial palsy and third degree rotatory nystagmus. She showed finger nose ataxia, incoordination of hand movements and a gait ataxia. Routine investigations were normal apart from an ESR of 26 mm/h. CT of the head and chest radiograph were normal. CSF contained 89 mononuclear cells/mm3 with an elevated protein of 1 4 g/l and no oligoclonal bands. She was treated with ACTH and the cerebellar syndrome improved within 24 hours. Despite subsequent improvement in the facial palsy she has permanent mild bilateral facial weakness. Since the original illness she has complained of persistent irritability, tension, depression, poor memory and concentration. Neuropsychological testing showed a pattern of cognitive deficit consistent with frontal and temporal lobe dysfunction rather than anxiety or depression. A 3 week course of intravenous penicillin and probenicid resulted in no improvement in these symptoms. Differences also exist from the neurological complications described in Lyme disease in which parenchymal involvement has been reported to be a major feature, with a number of patients suffering irreversible neurological deficits10 whereas the patients in our series had only mild transient parenchymal involvement. In the USA myelitis is not described as a definite complication of Lyme disease." However myelitis clearly does occur, since despite the much smaller experience of the disorder in Europe, one of our patients had cord involvement and a patient from Austria was recently described presenting with acute transverse myelitis.4 None of our patients developed new parenchymal lesions after their initial neurological illness which has been a feature of some American series.'0
The prognosis is generally good. The majority of our patients made a complete recovery with or without treatment. Two patients have residual facial palsies, and one a possible neuropsychiatric syndrome. None of our patients has relapsed during the study (2 years).
The pathogenesis of the neurological complications is uncertain. It has been suggested that they are immunological'2 rather than due to the continued presence of the organism. However, the organism has been cultured from the CSF'3 and there is good evidence that the meningeal features of the disease respond to parenteral penicillin."' Also similar clinical features are seen in the course of other infections, for example tuberculous meningitis, which are known to be due to the presence of the organism. Although peripheral nerve involvement does occur in B. burgdorferi infection, 5 this is generally mild in contrast to the severity of the radiculopathy. This is well illustrated by patient 4 whose nerve conduction studies showed mild distal slowing but considerable prolongation of the F wave latencies in keeping with the severe radiculopathy. These peripheral abnormalities may well be immunologically mediated but it seems likely that the common neurological manifestations of B. burgdorferi infection (Bannwarth's syndrome and a chronic meningitis) are due to the presence of the organism.
The best treatment of the neurological complications is uncertain. Erythema chronicum migrans and the neurological complications of B. burgdorferi infection occur in other parts of the British Isles.20 The diagnosis should be considered in unexplained cranial polyneuropathy, painful radiculopathy and chronic lymphocytic meningitis. The absence of a history of a tick bite or skin rash does not exclude the diagnosis since only a proportion of patients report them. Examination of the CSF is helpful in the diagnosis since a lymphocytic pleocytosis is common if not invariable and the finding of oligoclonal bands and intrathecal antibodies to B. burgdorferi has been shown to be a feature of most cases in other studies.2' The sensitivity and specificity of present serological tests is uncertain and positive serum B. burgdorferi titres may occur in other spirochaetal infections, connective tissue disorders and possibly CNS lymphoma.22 Although our experience to date suggests that the incidence of positive antibody titres (> 1:256) to B. burgdorferi is negligible in the normal population, the finding of an elevated serum antibody titre to B. burgdorferi alone cannot, for the reasons given above, be regarded as sufficient proof that the neurological disorder is due to that organism. 
